source
- Blackstone bets $1.5B on Pfizer’s obesity drugThe deal will support a sprawling Phase 3 program for a monthly GLP-1 shot Pfizer acquired by winning a bidding war for the drug’s previous owner, Metsera.BioPharma Dive · 2h ago↗ source
- Experts update prostate cancer screening guidelines for menAre you an American man between 50 and 69? You might want to get checked for prostate cancer, ACS says in reversal of previous guidelines.STAT · 7h ago↗ source
- Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator leadAbbott has received both FDA and CE Mark approval for its UltiSynq defibrillation lead tech, which is designed to deliver both conduction system pacing and defibrillation therapy.Fierce Biotech · 1d ago